Published in Biol Psychiatry on October 15, 2001
Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology (Berl) (2008) 2.64
Targeted ablation of cholinergic interneurons in the dorsolateral striatum produces behavioral manifestations of Tourette syndrome. Proc Natl Acad Sci U S A (2015) 1.59
Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice. Neuron (2014) 1.45
Neurobiological substrates of Tourette's disorder. J Child Adolesc Psychopharmacol (2010) 1.27
Prepulse inhibition and genetic mouse models of schizophrenia. Behav Brain Res (2009) 1.20
Impaired sensorimotor gating in unmedicated adults with obsessive-compulsive disorder. Neuropsychopharmacology (2012) 1.17
Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophr Res (2007) 1.11
Sensory aspects of movement disorders. Lancet Neurol (2014) 1.09
Sensory sensitivity to external stimuli in Tourette syndrome patients. Mov Disord (2011) 1.07
Two quantitative trait loci for prepulse inhibition of startle identified on mouse chromosome 16 using chromosome substitution strains. Genetics (2005) 1.00
The relationship between sensorimotor gating and clinical improvement in acutely ill schizophrenia patients. Schizophr Res (2006) 0.99
Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders. Curr Top Behav Neurosci (2012) 0.97
Separable noradrenergic and dopaminergic regulation of prepulse inhibition in rats: implications for predictive validity and Tourette Syndrome. Psychopharmacology (Berl) (2006) 0.96
Lesions of the dorsomedial striatum disrupt prepulse inhibition. Neuroscience (2011) 0.94
The effects of memantine on prepulse inhibition. Neuropsychopharmacology (2009) 0.92
Age-associated improvements in cross-modal prepulse inhibition in mice. Behav Neurosci (2010) 0.89
Impaired prepulse inhibition and prepulse-elicited reactivity but intact reflex circuit excitability in unmedicated schizophrenia patients: a comparison with healthy subjects and medicated schizophrenia patients. Schizophr Bull (2008) 0.87
Animal models of tic disorders: a translational perspective. J Neurosci Methods (2014) 0.87
Rat strain differences in startle gating-disruptive effects of apomorphine occur with both acoustic and visual prepulses. Pharmacol Biochem Behav (2007) 0.86
Reduced startle gating after D1 blockade: effects of concurrent D2 blockade. Pharmacol Biochem Behav (2005) 0.85
Analysis of TBX1 variation in patients with psychotic and affective disorders. Mol Med (2007) 0.85
Update: studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome. Neurosci Biobehav Rev (2012) 0.84
The D1CT-7 mouse model of Tourette syndrome displays sensorimotor gating deficits in response to spatial confinement. Br J Pharmacol (2015) 0.84
Prepulse inhibition of startle in adults with ADHD. J Psychiatr Res (2008) 0.83
The reelin receptors VLDLR and ApoER2 regulate sensorimotor gating in mice. Neuropharmacology (2007) 0.83
Ablation of fast-spiking interneurons in the dorsal striatum, recapitulating abnormalities seen post-mortem in Tourette syndrome, produces anxiety and elevated grooming. Neuroscience (2016) 0.83
Brain mechanisms for prepulse inhibition in adults with Tourette syndrome: initial findings. Psychiatry Res (2013) 0.82
The role of abnormal neural oscillations in the pathophysiology of co-occurring Tourette syndrome and attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry (2007) 0.81
Pre-attentive processing and schizophrenia: animal studies. Psychopharmacology (Berl) (2003) 0.80
Levetiracetam as an alternative therapy for Tourette syndrome. Neuropsychiatr Dis Treat (2010) 0.80
The implication of neuroactive steroids in Tourette's syndrome pathogenesis: A role for 5α-reductase? J Neuroendocrinol (2013) 0.79
Parametric approaches towards understanding the effects of the preferential D3 receptor agonist pramipexole on prepulse inhibition in rats. Pharmacol Biochem Behav (2010) 0.79
Sensory Phenomena in Tourette Syndrome: Their Role in Symptom Formation and Treatment. Curr Dev Disord Rep (2014) 0.78
Projections from ventral hippocampus to medial prefrontal cortex but not nucleus accumbens remain functional after fornix lesions in rats. Neuroscience (2010) 0.78
A novel visuospatial priming task for rats with relevance to Tourette syndrome and modulation of dopamine levels. Neurosci Biobehav Rev (2012) 0.77
Prepulse inhibition of startle response: recent advances in human studies of psychiatric disease. Clin Psychopharmacol Neurosci (2011) 0.77
Neural correlates of sensorimotor gating: a metabolic positron emission tomography study in awake rats. Front Behav Neurosci (2014) 0.77
Inter-hemispheric Intrinsic Connectivity as a Neuromarker for the Diagnosis of Boys with Tourette Syndrome. Mol Neurobiol (2016) 0.76
Genetic susceptibility and neurotransmitters in Tourette syndrome. Int Rev Neurobiol (2013) 0.76
What makes you tic? Translational approaches to study the role of stress and contextual triggers in Tourette syndrome. Neurosci Biobehav Rev (2016) 0.76
Assessment of gait and sensorimotor deficits in the D1CT-7 mouse model of Tourette syndrome. J Neurosci Methods (2017) 0.75
Simultaneous EMG-fMRI during startle inhibition in monosymptomatic enuresis--an exploratory study. Eur J Pediatr (2012) 0.75
Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy. Front Pharmacol (2016) 0.75
Phospholipase C-β1 Hypofunction in the Pathogenesis of Schizophrenia. Front Psychiatry (2015) 0.75
Pediatric Autoimmune Disorders Associated with Streptococcal Infections and Tourette's Syndrome in Preclinical Studies. Front Neurosci (2016) 0.75
Clerodendrum inerme Leaf Extract Alleviates Animal Behaviors, Hyperlocomotion, and Prepulse Inhibition Disruptions, Mimicking Tourette Syndrome and Schizophrenia. Evid Based Complement Alternat Med (2012) 0.75
Histidine Decarboxylase Knockout Mice as a Model of the Pathophysiology of Tourette Syndrome and Related Conditions. Handb Exp Pharmacol (2017) 0.75
Modeling tics in rodents: Conceptual challenges and paths forward. J Neurosci Methods (2017) 0.75
Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) (2001) 5.67
Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry (1990) 4.08
Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl) (2001) 4.03
Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav Pharmacol (2000) 3.03
Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry (1992) 2.72
Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci U S A (1997) 2.12
Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning. EMBO J (1998) 2.07
Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis. Cancer Res (1996) 1.90
Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry (1994) 1.90
Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology (Berl) (1988) 1.80
Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach. Mol Psychiatry (2004) 1.76
Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. J Neurosci (1999) 1.69
Identification of blood biomarkers for psychosis using convergent functional genomics. Mol Psychiatry (2009) 1.68
A freshwater anaerobe coupling acetate oxidation to tetrachloroethylene dehalogenation. Appl Environ Microbiol (1996) 1.66
Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. J Neurol Neurosurg Psychiatry (1995) 1.64
Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses. Pharmacol Biochem Behav (1986) 1.56
Towards understanding the schizophrenia code: an expanded convergent functional genomics approach. Am J Med Genet B Neuropsychiatr Genet (2007) 1.55
Titanium plate fixation: a review of implant failures. J Orthop Trauma (1996) 1.55
c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype. Cancer Res (1998) 1.54
Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr Res (2001) 1.54
Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists. J Neurosci (2001) 1.54
Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull (1998) 1.53
A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biol Psychiatry (1993) 1.52
Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis. Oncogene (2008) 1.48
Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology (Berl) (1995) 1.48
Effect of leucine metabolite beta-hydroxy-beta-methylbutyrate on muscle metabolism during resistance-exercise training. J Appl Physiol (1985) (1996) 1.42
Variation in human intestinal microbiota with age. Dig Liver Dis (2002) 1.41
Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide. Psychopharmacology (Berl) (1986) 1.38
Poor P50 suppression among schizophrenia patients and their first-degree biological relatives. Am J Psychiatry (1998) 1.38
A systems model of altered consciousness: integrating natural and drug-induced psychoses. Brain Res Bull (2001) 1.36
Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers. Cell Growth Differ (1996) 1.36
Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications. Am J Psychiatry (2000) 1.35
Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. Am J Psychiatry (2000) 1.29
Impaired postnatal development of hippocampal dentate gyrus in Sp4 null mutant mice. Genes Brain Behav (2006) 1.28
Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology (1989) 1.26
Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists. J Neurosci (2000) 1.24
Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther (1994) 1.23
Responsiveness of the Manchester-Oxford Foot Questionnaire (MOXFQ) compared with AOFAS, SF-36 and EQ-5D assessments following foot or ankle surgery. J Bone Joint Surg Br (2012) 1.21
Physiological evidence of exaggerated startle response in a subgroup of Vietnam veterans with combat-related PTSD. Am J Psychiatry (1990) 1.21
Prepulse inhibition deficits in patients with panic disorder. Depress Anxiety (2002) 1.20
Hypertrophic gastropathy resembling Ménétrier's disease in transgenic mice overexpressing transforming growth factor alpha in the stomach. J Clin Invest (1992) 1.20
The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity. Neuropharmacology (2002) 1.19
Assessment of a prepulse inhibition deficit in a mutant mouse lacking mGlu5 receptors. Mol Psychiatry (2004) 1.19
Habituation of the Blink reflex in normals and schizophrenic patients. Psychophysiology (1982) 1.19
Reduced expression of the Sp4 gene in mice causes deficits in sensorimotor gating and memory associated with hippocampal vacuolization. Mol Psychiatry (2005) 1.18
The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice. J Neurosci (1999) 1.18
Increased exploratory activity and altered response to LSD in mice lacking the 5-HT(5A) receptor. Neuron (1999) 1.18
Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biol Psychiatry (1986) 1.17
Symptom correlates of prepulse inhibition deficits in male schizophrenic patients. Am J Psychiatry (1999) 1.16
Men are more inhibited than women by weak prepulses. Biol Psychiatry (1993) 1.15
Strain-specific effects of amphetamine on prepulse inhibition and patterns of locomotor behavior in mice. J Pharmacol Exp Ther (2001) 1.14
Deficits in parvalbumin and calbindin immunoreactive cells in the hippocampus of isolation reared rats. J Neural Transm (Vienna) (2007) 1.14
The neural substrates of sensorimotor gating of the startle reflex: a review of recent findings and their implications. J Psychopharmacol (1992) 1.13
Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats. J Pharmacol Exp Ther (1988) 1.13
5-hydroxytryptamine2A receptor inverse agonists as antipsychotics. J Pharmacol Exp Ther (2001) 1.11
Phenomic, convergent functional genomic, and biomarker studies in a stress-reactive genetic animal model of bipolar disorder and co-morbid alcoholism. Am J Med Genet B Neuropsychiatr Genet (2008) 1.11
Environmental enrichment and isolation rearing in the rat: effects on locomotor behavior and startle response plasticity. Biol Psychiatry (2000) 1.10
Cross-species studies of sensorimotor gating of the startle reflex. Ann N Y Acad Sci (1999) 1.10
Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients. Arch Gen Psychiatry (1999) 1.09
A temporal and spatial scaling hypothesis for the behavioral effects of psychostimulants. Psychopharmacology (Berl) (1991) 1.09
Delayed procedural learning in α7-nicotinic acetylcholine receptor knockout mice. Genes Brain Behav (2011) 1.08
Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder. Am J Psychiatry (1993) 1.07
Neurochemical mechanisms involved in behavioral effects of amphetamines and related designer drugs. NIDA Res Monogr (1989) 1.07
Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats. J Pharmacol Exp Ther (1990) 1.07
Increased distractibility in schizophrenic patients. Electrophysiologic and behavioral evidence. Arch Gen Psychiatry (1990) 1.06
Convergent functional genomics of anxiety disorders: translational identification of genes, biomarkers, pathways and mechanisms. Transl Psychiatry (2011) 1.06
P50 suppression among schizophrenia and normal comparison subjects: a methodological analysis. Biol Psychiatry (1997) 1.05
Prepulse startle deficit in the Brown Norway rat: a potential genetic model. Behav Neurosci (2000) 1.05
Molecular and genetic analysis of liver oncogenesis in transforming growth factor alpha transgenic mice. Cancer Res (1992) 1.05
Three independent factors characterize spontaneous rat motor activity. Behav Brain Res (1993) 1.04
Information processing deficits of schizophrenia patients: relationship to clinical ratings, gender and medication status. Schizophr Res (1997) 1.04
Multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist dizocilpine. J Neurosci (1998) 1.04
Responding to acoustic startle during chronic ethanol intoxication and withdrawal. Psychopharmacology (Berl) (1992) 1.03
Prepulse inhibition and habituation of the startle response are stable neurobiological measures in a normal male population. Biol Psychiatry (1999) 1.02
Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice. Neuropharmacology (2000) 1.02
Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacol Biochem Behav (1993) 1.01
Gating and habituation deficits in the schizophrenia disorders. Clin Neurosci (1995) 1.01
Reverse translation of the rodent 5C-CPT reveals that the impaired attention of people with schizophrenia is similar to scopolamine-induced deficits in mice. Transl Psychiatry (2013) 1.00
Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine. Psychopharmacology (Berl) (1995) 1.00
The Manchester-Oxford Foot Questionnaire (MOXFQ): Development and validation of a summary index score. Bone Joint Res (2013) 0.99
Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat. J Pharmacol Exp Ther (1991) 0.99
Effects of hallucinogens on locomotor and investigatory activity and patterns: influence of 5-HT2A and 5-HT2C receptors. Neuropsychopharmacology (1998) 0.99
M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats. Neuropsychopharmacology (1999) 0.98
Serotonin1B receptor modulation of startle reactivity, habituation, and prepulse inhibition in wild-type and serotonin1B knockout mice. Psychopharmacology (Berl) (1997) 0.98
The MOXFQ patient-reported questionnaire: assessment of data quality, reliability and validity in relation to foot and ankle surgery. Foot (Edinb) (2011) 0.98
Insoluble DISC1-Boymaw fusion proteins generated by DISC1 translocation. Mol Psychiatry (2010) 0.98
"Normal" personality correlates of sensorimotor, cognitive, and visuospatial gating. Biol Psychiatry (1995) 0.98
Multiple site evaluation of P50 suppression among schizophrenia and normal comparison subjects. Schizophr Res (1998) 0.98
Seroquel restores sensorimotor gating in phencyclidine-treated rats. J Pharmacol Exp Ther (1996) 0.97
Apomorphine disrupts the inhibition of acoustic startle induced by weak prepulses in rats. Psychopharmacology (Berl) (1990) 0.97
Comparison of microbial populations in model and natural rumens using 16S ribosomal RNA-targeted probes. Environ Microbiol (2000) 0.97
Regulation of terminal differentiation of zymogenic cells by transforming growth factor alpha in transgenic mice. Gastroenterology (1995) 0.97
Application of entropy measures derived from the ergodic theory of dynamical systems to rat locomotor behavior. Proc Natl Acad Sci U S A (1990) 0.97
Use of methods from chaos theory to quantify a fundamental dysfunction in the behavioral organization of schizophrenic patients. Am J Psychiatry (1996) 0.97
Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats. Neuropharmacology (1994) 0.96
Psychopharmacology of prepulse inhibition in mice. Chin J Physiol (1996) 0.96
A D2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia. Neuropsychopharmacology (1990) 0.96
Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats. Psychopharmacology (Berl) (1998) 0.95
Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin. Neuropsychopharmacology (2001) 0.95